Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INGAP Peptide in Insulin-using Type 2 Diabetes
NCT00071422Phase 2Completed
- Sponsor
- Exsulin
- Start
- Oct 2003
- Primary completion
- Jun 2004
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of INGAP peptide in type 2 diabetes mellitus (T2DM), sponsored by Exsulin. Started Oct 2003; status: completed.
02
Drugs
INGAP peptide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00071422.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00071422.